173 related articles for article (PubMed ID: 35993185)
1. Characterizing the immune microenvironment for nodular lymphocyte-predominant Hodgkin lymphoma.
Binkley MS
Br J Haematol; 2022 Nov; 199(3):310-312. PubMed ID: 35993185
[TBL] [Abstract][Full Text] [Related]
2. Immunoarchitectural patterns in nodular lymphocyte predominant Hodgkin lymphoma: pathologic and clinical implications.
Gloghini A; Bosco A; Ponzoni M; Spina M; Carbone A
Expert Rev Hematol; 2015 Apr; 8(2):217-23. PubMed ID: 25487651
[TBL] [Abstract][Full Text] [Related]
3. Tumour cell characteristics and microenvironment composition correspond to clinical presentation in newly diagnosed nodular lymphocyte-predominant Hodgkin lymphoma.
Hartmann S; Soltani AS; Bankov K; Bein J; Hansmann ML; Rosenwald A; Bernd HW; Feller A; Ott G; Möller P; Stein H; Klapper W; Borchmann P; Engert A; Eichenauer DA
Br J Haematol; 2022 Nov; 199(3):382-391. PubMed ID: 35880396
[TBL] [Abstract][Full Text] [Related]
4. Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Review of Current Literature and Case Discussion.
Sidda A; Naleid NK; Manu G; Graffeo V; Jamil MO
J Investig Med High Impact Case Rep; 2022; 10():23247096221111767. PubMed ID: 35861500
[TBL] [Abstract][Full Text] [Related]
5. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
Hartmann S; Dojcinov S; Dotlic S; Gibson SE; Hsi ED; Klapper W; Klimkowska M; Pinilla SMR; Richter J; Sabattini E; Tousseyn T; de Jong D
Virchows Arch; 2023 Oct; 483(4):451-463. PubMed ID: 37530790
[TBL] [Abstract][Full Text] [Related]
7. [IgD expression in various immunoarchitectural patterns of nodular lymphocyte predominant Hodgkin lymphoma in children].
Senchenko MA; Konovalov DM
Arkh Patol; 2024; 86(1):21-26. PubMed ID: 38319268
[TBL] [Abstract][Full Text] [Related]
8. Immunoarchitectural patterns of progressive transformation of germinal centers with and without nodular lymphocyte-predominant Hodgkin lymphoma.
Hartmann S; Winkelmann R; Metcalf RA; Treetipsatit J; Warnke RA; Natkunam Y; Hansmann ML
Hum Pathol; 2015 Nov; 46(11):1655-61. PubMed ID: 26410017
[TBL] [Abstract][Full Text] [Related]
9. Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Panayi C; Akarca AU; Ramsay AD; Shankar AG; Falini B; Piris MA; Linch D; Marafioti T
Front Oncol; 2023; 13():1267604. PubMed ID: 37854674
[TBL] [Abstract][Full Text] [Related]
10. Specific Polo-Like Kinase 1 Expression in Nodular Lymphocyte-Predominant Hodgkin Lymphoma Suggests an Intact Immune Surveillance Program.
Weiss J; Gibbons K; Ehyaee V; Perez-Silos V; Zevallos A; Maienschein-Cline M; Brister E; Sverdlov M; Shah E; Balakrishna J; Symes E; Frederiksen JK; Gann PH; Post R; Lopez-Hisijos N; Reneau J; Venkataraman G; Bailey N; Brown NA; Xu ML; Wilcox RA; Inamdar K; Murga-Zamalloa C
Am J Pathol; 2024 Jan; 194(1):165-178. PubMed ID: 37923249
[TBL] [Abstract][Full Text] [Related]
11. CD20-Negative Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A 20-Year Consecutive Case Series From a Tertiary Cancer Center.
Menke JR; Spinner MA; Natkunam Y; Warnke RA; Advani RH; Gratzinger DA
Arch Pathol Lab Med; 2021 Jun; 145(6):753-758. PubMed ID: 32991677
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the Microenvironment of Nodular Lymphocyte Predominant Hodgkin Lymphoma.
Visser L; Rutgers B; Diepstra A; van den Berg A; Sattarzadeh A
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999289
[TBL] [Abstract][Full Text] [Related]
13. Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?
Hartmann S; Döring C; Jakobus C; Rengstl B; Newrzela S; Tousseyn T; Sagaert X; Ponzoni M; Facchetti F; de Wolf-Peeters C; Steidl C; Gascoyne R; Küppers R; Hansmann ML
PLoS One; 2013; 8(11):e78812. PubMed ID: 24244368
[TBL] [Abstract][Full Text] [Related]
14. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
Younes S; Subramanian A; Khan A; Zhao S; Binkley M; Natkunam Y
Blood Cancer J; 2024 May; 14(1):92. PubMed ID: 38821935
[TBL] [Abstract][Full Text] [Related]
15. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
[TBL] [Abstract][Full Text] [Related]
16. Nodular lymphocyte-predominant Hodgkin lymphoma.
Savage KJ; Mottok A; Fanale M
Semin Hematol; 2016 Jul; 53(3):190-202. PubMed ID: 27496311
[TBL] [Abstract][Full Text] [Related]
17. The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG).
Hartmann S; Eichenauer DA; Plütschow A; Mottok A; Bob R; Koch K; Bernd HW; Cogliatti S; Hummel M; Feller AC; Ott G; Möller P; Rosenwald A; Stein H; Hansmann ML; Engert A; Klapper W
Blood; 2013 Dec; 122(26):4246-52; quiz 4292. PubMed ID: 24100447
[TBL] [Abstract][Full Text] [Related]
18. Practice patterns for the management of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): an international survey by the Global NLPHL One Working Group (GLOW).
Lo AC; Major A; Super L; Appel B; Shankar A; Constine LS; Marks LJ; Kelly KM; Metzger ML; Buhtoiarov IN; Mauz-Körholz C; Costa ARS; Binkley MS; Flerlage J
Leuk Lymphoma; 2022 Aug; 63(8):1997-2000. PubMed ID: 35357263
[No Abstract] [Full Text] [Related]
19. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
[TBL] [Abstract][Full Text] [Related]
20. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
Hartmann S; Cogliatti S; Hansmann ML
Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]